Doceree launched Semmelweis, an artificial intelligence reasoning and orchestration model built specifically for pharmaceutical commercialization, the company announced.1 The model underpins Daily Command , Doceree's newly launched commercial operating system for pharma, and the rest of the company's product suite. Our model is built to see the signal early — and to act on it only within the guardrails this industry rightly demands. Semmelweis reasons behind Daily Command as well as Doceree's Clinical Intent Suite, RepTwin field-agent tool, Co-pay.com and the Doceree Marketplace, according to the company. The launch comes as large pharmaceutical companies increase AI investment in commercial operations, not only in research and development. "2 Bourla said AI is helping the company "accelerate new product launches, deliver insights for dynamic targeting, and support personalized messaging and real-time marketing content" in its commercial function.